Phathom Pharmaceuticals, Inc. short interest in 2023
In 2023, Phathom Pharmaceuticals, Inc.'s disclosed short interest ran from 5.02% of shares outstanding on 13 Jan 2023 to 12.36% on 29 Dec 2023, a change of +7.34 percentage points. The year's high was 12.36% on 29 Dec 2023 and its low 4.56% on 15 Aug 2023, averaging 8.29% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.89 days on 28 Apr 2023. Full history: Phathom Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 5.02% (13 Jan 2023)
- End of year
- 12.36% (29 Dec 2023)
- Change
- +7.34 pp
- High
- 12.36% (29 Dec 2023)
- Low
- 4.56% (15 Aug 2023)
- Average
- 8.29%
- Highest days to cover
- 20.89 (28 Apr 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 5.02% | 3.12 | |
| 31 Jan 2023 | 5.46% | 6.68 | |
| 15 Feb 2023 | 6.46% | 5.08 | |
| 28 Feb 2023 | 7.10% | 7.36 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 7.30% | 8.82 | |
| 31 Mar 2023 | 8.64% | 12.05 | |
| 14 Apr 2023 | 11.56% | 7.02 | |
| 28 Apr 2023 | 11.60% | 20.89 | |
| 15 May 2023 | 10.78% | 11.86 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.90% | 7.44 | |
| 15 Jun 2023 | 10.40% | 16.98 | |
| 30 Jun 2023 | 10.07% | 10.39 | |
| 14 Jul 2023 | 10.25% | 17.76 | |
| 31 Jul 2023 | 7.60% | 16.72 | |
| 15 Aug 2023 | 4.56% | 6.94 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 4.87% | 10.63 | |
| 15 Sep 2023 | 4.86% | 5.43 | |
| 29 Sep 2023 | 6.90% | 7.92 | |
| 13 Oct 2023 | 6.95% | 13.47 | |
| 31 Oct 2023 | 7.25% | 11.87 | |
| 15 Nov 2023 | 8.50% | 6.10 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 9.61% | 12.31 | |
| 15 Dec 2023 | 10.95% | 9.59 | |
| 29 Dec 2023 | 12.36% | 20.16 |
See also: Phathom Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.